JPRN-UMIN000030648已完成未知
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 Units/mL and insulin glulisine (Basal plus therapy). - Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 Units/mL and insulin glulisine (Basal plus therapy).
Minami Osaka hospital0 个研究点目标入组 20 人开始时间: 2018年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Serious ketosis, history of diabetic coma or precoma 2.Pregnancy or lactation and patients scheduled 3.Serious infection, trauma, undergo surgery 4.Receiving steroid therapy. 5.Severe liver dysfunction 6.Type 1 diabetes 7.Hypersensitivity to degludec/aspart, glargin, glulisine. 8.History of malignancy or malignancy. 9.Judged to be unsuitable for participation for medical reasons.
研究者
相似试验
已完成
不适用
Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapytype 2 diabetesJPRN-UMIN000013872Juntendo University Graduate School of Medicine60
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 1 diabetes with the Basal-Bolus TherapyType 1 diabetesJPRN-UMIN000012358Toho University School of Medicine, Division of diabetes, metabolism and endocrinology20
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 2 diabetes with the Basal-Bolus TherapyJPRN-UMIN000015792Toho University School of Medicine, Division of diabetes, metabolism and endocrinology40
招募中
不适用
Comparison of efficacy and safety of insulin glargine U-100/lixisenatide and insulin degludec/liraglutide in type 2 diabetes patientstype 2 Diabetes mellitusJPRN-UMIN000047518Minami Osaka Hospital36
尚未招募
不适用
Comparative efficacy and safety of antidiabetic drugs in treating diabetes mellitusType 2 DiabetesJPRN-UMIN000032496The University of Tokyo10,000